NVO - Amgen weight loss drug shows promising early data
2024-02-05 06:35:53 ET
More on Amgen
- Amgen: Debt-Funded Buybacks Constrains Future Gains Per Share
- Amgen: Accelerating The Business And Dividend Growth
- Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
- Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
- FDA issues boxed warning for Amgen's osteoporosis drug